Back to search results

Healing at Home 2.0 for Lowering Postpartum Depression

This study is testing if a text-message based support program called "Healing at Home 2.0" can help reduce symptoms of depression after childbirth. This program offers 24/7 support through a chatbot for six weeks after you give birth. We are looking for women of color, aged 18 or older, who have recently delivered a single baby at the Hospital of the University of Pennsylvania and can speak, read, and write English. The main goal is to see if participants using "Healing at Home 2.0" have lower depression scores compared to those receiving usual postpartum care. The current status of this study is unclear, and it plans to enroll 156 participants.

Study design
This is an interventional study that will randomly assign participants to either receive the "Healing at Home 2.0" program or usual postpartum care. It aims to enroll 156 participants.
What's involved
Participants will use the "Healing at Home 2.0" text message chatbot for six weeks postpartum, or receive usual postpartum care. Your depression symptoms will be measured at 6 weeks postpartum.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for their Edinburgh Postnatal Depression Scale (EPDS) score at 6 weeks postpartum.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06877104

Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression

Active, Not Recruiting
NAAges 18+InterventionalSupportive care
University of Pennsylvania
~156 participants
Updated 2026-08-21 on ClinicalTrials.gov
What's tested:Healing @ Home Program (H@H 2.0)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Edinburgh Postnatal Depression Scale (EPDS) Screening Score
Measured over At 6 weeks postpartum

Conditions

Depression, Postpartum
Postpartum Care

Explore related trials

Postpartum Depression

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Kirstin Leitner, MD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania
Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)
Able to speak, read and write English
Age ≥18
Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania
Completion of clinically administered EPDS during inpatient stay
Routine discharge timing, day 2 or more after vaginal delivery, day 3 or more after cesarean delivery

Exclusion

Unable to provide informed consent
Baby not discharged with mother at postpartum discharge
Does not have access to a mobile phone

What this trial measures

  • Edinburgh Postnatal Depression Scale (EPDS) Screening ScoreAt 6 weeks postpartum

    Scores from the validated EPDS screening tool will be calculated using standard scoring criteria for each of the 10 items. A score of 9 or greater or indication of suicide ideation will be used to indicate a positive depression screen.